These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15149847)

  • 1. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
    Figueroa JD; Hayman MJ
    Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
    Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
    Avila T; Andrade A; Felix R
    J Cell Physiol; 2006 Nov; 209(2):448-56. PubMed ID: 16883604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
    de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
    J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12.
    Yeh LC; Tsai AD; Lee JC
    J Cell Biochem; 2002; 87(3):292-304. PubMed ID: 12397611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2.
    Chung CY; Iida-Klein A; Wyatt LE; Rudkin GH; Ishida K; Yamaguchi DT; Miller TA
    Biochem Biophys Res Commun; 1999 Nov; 265(1):246-51. PubMed ID: 10548521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
    Yeh LC; Tsai AD; Zavala MC; Lee JC
    J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage.
    Okubo Y; Bessho K; Fujimura K; Iizuka T; Miyatake S
    Biochem Biophys Res Commun; 1999 Sep; 262(3):739-43. PubMed ID: 10471395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human valve interstitial cells in valve calcification and their response to atorvastatin.
    Osman L; Yacoub MH; Latif N; Amrani M; Chester AH
    Circulation; 2006 Jul; 114(1 Suppl):I547-52. PubMed ID: 16820635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.
    Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T
    Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells.
    de Jong DS; Steegenga WT; Hendriks JM; van Zoelen EJ; Olijve W; Dechering KJ
    Biochem Biophys Res Commun; 2004 Jul; 320(1):100-7. PubMed ID: 15207708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts.
    Fux C; Mitta B; Kramer BP; Fussenegger M
    Nucleic Acids Res; 2004 Jan; 32(1):e1. PubMed ID: 14704358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.